SPOTLIGHT -
Dr. Badani on the Evolution of Robotic Retroperitoneal Partial Nephrectomies in RCC
Ketan K. Badani, MD, discusses the evolution of robotic retroperitoneal partial nephrectomies in renal cell carcinoma.
Read More
Dr. Badani on Utilizing Multiport Robotic Retroperitoneal Partial Nephrectomies in RCC
Ketan K. Badani, MD, discusses the utility of multiport robotic retroperitoneal partial nephrectomies in renal cell carcinoma (RCC).
Dr. Badani on Determining Which Patients With RCC Will Receive Robotic Surgery
Ketan K. Badani, MD, professor of urology at Mount Sinai Hospital, discusses how to determine which patient with renal cell carcinoma (RCC) will benefit from robotic surgery.
Dr. Badani Discusses the Adoption of Robotic Kidney Surgery
Ketan K. Badani, MD, professor of urology at Mount Sinai Hospital, discusses the adoption of robotic surgery in kidney cancer.
Dr. Badani on the Future of Robotic Surgery for Kidney Cancer
Ketan K. Badani, MD, professor of Urology at Mount Sinai Hospital, discusses the future of robotic surgery for patients with kidney cancer.
Dr. Badani on the Benefits of Robotic Surgery for Kidney Cancer
Ketan K. Badani, MD, professor of Urology at Mount Sinai Hospital, discusses the benefits of performing a partial robotic nephrectomy for patients with kidney cancer.
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
